Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)

BACKGROUND: The conventional treatment options for advanced gastric patients remain unsatisfactory in terms of response rate, response duration, toxicity, and overall survival benefit. The purpose of this phase II study was to evaluate the activity and safety of cetuximab combined with cisplatin and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pinto, C, Di Fabio, F, Barone, C, Siena, S, Falcone, A, Cascinu, S, Rojas Llimpe, F L, Stella, G, Schinzari, G, Artale, S, Mutri, V, Giaquinta, S, Giannetta, L, Bardelli, A, Martoni, A A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768436/
https://ncbi.nlm.nih.gov/pubmed/19773760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605319
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados